CONNECTS

New clinical milestones reached as multiple COVID-19 vaccines and therapies advance

Plans for a late-stage test of Valneva SE's COVID-19 vaccine candidate, clinical progress on a different vaccine from Novavax Inc. and advancement for two midstage therapies targeting the virus made clear April 6 that industry efforts to battle the pandemic remain in high gear.

Read More

38% of Detroit residents ‘very likely’ to get COVID-19 vaccine, University of Michigan survey finds

More Detroit residents are “very likely” to get the COVID-19 vaccine compared to last fall, a University of Michigan survey found.

Read More

U-M Receives $1.4M in NIH Funding to expand COVID-19 outreach

Being deeply rooted in the wellbeing of Michigan communities meant that the Community Engagement program at the Michigan Institute for Clinical & Health Research, Michigan Medicine, and the U-M School of Public Health were on the frontlines when the pandemic hit the nation.

Read More